Treatment of Clostridioides difficile Infection Symptoms
Fidaxomicin 200 mg twice daily for 10 days is the preferred first-line treatment for Clostridioides difficile infection (CDI) due to superior sustained clinical response rates and lower recurrence rates. 1
First-Line Treatment Options
Non-Severe Initial CDI
Vancomycin: 125 mg orally four times daily for 10 days 1, 3
- Alternative first-line option
- FDA-approved for C. difficile-associated diarrhea 3
Metronidazole: 500 mg orally three times daily for 10-14 days 1
- Consider only when fidaxomicin and vancomycin are unavailable
- Particularly for patients ≤65 years old
- Not preferred due to higher failure and recurrence rates
Severe CDI
Severe CDI is characterized by hypotension, shock, ileus, or megacolon, with risk factors including:
- Age >60 years
- Fever
- Hypoalbuminemia
- Peripheral leukocytosis
- ICU stay
- Abnormal abdominal CT findings 1
Treatment for severe CDI:
- Vancomycin: 500 mg orally four times daily 1
- If ileus is present, add rectal instillation of vancomycin
- Plus intravenous metronidazole 500 mg every 8 hours
Pediatric Treatment
- For children ≥6 months: Fidaxomicin (FDA-approved) 2
- Alternative: Metronidazole 7.5 mg/kg/dose (maximum 500 mg) three or four times daily for 10 days 1
- For children <18 years with C. difficile-associated diarrhea: Vancomycin 40 mg/kg/day in 3-4 divided doses for 7-10 days (not to exceed 2g daily) 3
Treatment of Recurrent CDI
First Recurrence
- Fidaxomicin: 200 mg twice daily for 10 days OR
- Fidaxomicin: 200 mg twice daily for 5 days followed by once every other day for 20 days 1
Second or Subsequent Recurrence
- Consider fecal microbiota transplantation (FMT) after appropriate antibiotic treatments for at least 2 recurrences
- FMT shows 70-90% success rates in preventing further recurrences 1, 4
Monitoring and Follow-up
- Expect improvement within 2-3 days of starting treatment
- If no improvement occurs within 48-72 hours:
- Reassess severity
- Consider alternative treatments 1
- Monitor for side effects:
Infection Control Measures
- Strict hand hygiene with soap and water (not alcohol-based sanitizers)
- Contact precautions and isolation
- Thorough environmental cleaning
- Discontinue the inciting antibiotic as soon as possible 1
Adjunctive Therapy
- Bezlotoxumab: 10 mg/kg IV once during antibiotic administration may be considered, particularly for immunocompromised patients 1
Important Caveats
- Oral vancomycin and fidaxomicin are not effective for other types of infections 3, 2
- Avoid prolonged or repeated courses of metronidazole due to risk of cumulative and potentially irreversible neurotoxicity 1
- Approximately 20% of patients may experience relapse when treatment is discontinued 5
- For elderly patients with severe or fulminant CDI who fail standard therapy, FMT should be considered before surgical intervention due to high post-surgical mortality rates approaching 30% in this population 4